Key facts
- It has raised $5.5M; the latest was Seed Round ($5.0M) in Nov 2025.
- Notable investors include Y Combinator, Pioneer Fund, Peak XV Partners, Kevin Moore, 1984 Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for SynthioLabs
- ·The full record, as it builds
Funding rounds
No funding rounds for SynthioLabs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SynthioLabs
Developer of clinical-grade voice and artificial intelligence platforms designed to improve pharmaceutical customer engagement through real-time access to compliant, evidence-based information. The company offers voice and multimodal agents that support field teams, healthcare professionals, and patients, enabling pharmaceutical organizations to enhance engagement quality, strengthen operational efficiency, and achieve clearer commercial outcomes.
- Sector
- Information Technology
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Employees
- 25
- Website
- synthiolabs.com/
- Ownership
- Privately Held (backing)
SynthioLabs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SynthioLabs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SynthioLabs in its N-PORT filings yet. We sweep new filings monthly.